Report of Foreign Issuer (6-k)
September 18 2018 - 8:48AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
6-K
REPORT OF A
FOREIGN ISSUER
PURSUANT TO RULE
13A-16
OR
15D-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For September 18, 2018
Commission File Number
1-38455
MorphoSys AG
Semmelweisstrasse 7
82152 Planegg
Germany
(Address of principal executive offices)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form
20-F
or Form
40-F.
Form
20-F ☒ Form
40-F ☐
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule
12g3-2(b)
under the Securities Exchange Act of 1934.
Yes ☐ No ☒
If ‘‘Yes’’ is marked, indicate below the file number assigned to the registrant in connection with Rule
12g3-2(b):
Exhibits
|
|
|
|
|
|
|
|
99.1
|
|
MorphoSys and LEO Pharma Expand Strategic Alliance to Develop Peptide-derived Therapeutics
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
MORPHOSYS AG (Registrant)
|
|
|
|
|
|
Date: September 18, 2018
|
|
By:
|
|
/s/ Jens Holstein
|
|
|
|
|
|
Name:
|
|
Jens Holstein
|
|
|
|
|
|
Title:
|
|
CFO
|
|
|
|
|
|
|
|
By:
|
|
/s/ Hans-Joachim Orlowski
|
|
|
|
|
|
Name:
|
|
Hans-Joachim Orlowski
|
|
|
|
|
|
Title:
|
|
Associate Director Corporate Communications and Investor Relations
|
MorphoSys (NASDAQ:MOR)
Historical Stock Chart
From Jun 2024 to Jul 2024
MorphoSys (NASDAQ:MOR)
Historical Stock Chart
From Jul 2023 to Jul 2024
